![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 24, 22010-22017, June 14, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Molecular Medicine Unit, Department of Medicine, Beth
Israel Deaconess Medical Center and Harvard Medical School,
Boston, Massachusetts 02215
Received for publication, December 28, 2001, and in revised form, April 2, 2002
The biogenesis of apolipoprotein B is quite
complex in view of its huge size, hydrophobicity, obligate association
with lipids such as cholesterol and triglycerides prior to secretion,
and intracellular degradation of a substantial proportion of newly synthesized molecules. Multiple proteins likely serve roles as molecular chaperones to assist in folding, assembly with lipids, and
regulation of the secretion of apolipoprotein B. In these studies, we
developed a strategy to isolate proteins associated with
apolipoprotein B in rat livers. The purification consisted of two
stages: first, microsomes were prepared from rat liver and treated with
chemical cross-linkers, and second, the solubilized proteins were
co-immunoprecipitated with antibody against apolipoprotein B. We found
that several proteins were cross-linked to apolipoprotein B. The
proteins were digested with trypsin, and the released peptides were
sequenced by tandem mass spectrometry. The sequences precisely matched
377 peptides in 99 unique proteins. We show that at least two of the
identified proteins, ferritin heavy and light chains, can directly bind
apolipoprotein B. These and possibly other proteins identified by this
proteomic approach are novel candidates for proteins that affect
apolipoprotein B during its biogenesis.
Apolipoprotein B (apoB)1
is secreted with lipids including cholesterol esters, phospholipids,
cholesterol, and triglycerides, as very low density lipoproteins
(1-5). The secretion of cholesterol from the liver in humans is tied
to the export of apoB into plasma. Hepatic regulation of apoB secretion
is chiefly posttranslational (6); secretion reflects the balance
between assembly of this protein with lipids into a lipoprotein
particle and intracellular degradation. Both of these competing
processes appear to involve several other proteins.
The biogenesis of this large (molecular mass greater than 500 kDa) (7,
8), hydrophobic protein requires the participation of several known
chaperone proteins including some that are particular to the
specialized physiologic role of apoB. Evidence suggests that calnexin,
calreticulin, BiP, Erp72, GRP94, and protein disulfide isomerase (PDI)
all interact with apoB during its translocation and further biogenesis
once it has entered the endoplasmic reticulum (ER) (9-11). These
proteins also function in the proper folding and quality control of
other secretory proteins. However, the assembly of apoB with lipids
into a lipoprotein particle necessitates additional proteins that may
be particular to apoB. The lack of solubility of apoB in an aqueous
environment, such as the lumen of the ER, necessitates its
co-translational association with lipids (12). This process is
facilitated by microsomal triglyceride transport protein (MTP), which
plays a crucial role in the initial assembly and regulation of
secretion of apoB (13-15). In a second step that is sensitive to
inhibition by brefeldin A, apoB is assembled with a full complement of
lipids into a mature lipoprotein particle (16, 17). The protein that
mediates this addition of bulk lipids is not known.
Molecules of apoB that do not complete the assembly process due to
insufficient lipids being available, misfolding, or inhibition of
necessary chaperone proteins are targeted for intracellular degradation. Several groups have shown that apoB can be marked for
degradation by the ubiquitin-proteasome pathway even during its
translocation into the ER (18-20). ApoB can also enter other routes of
intracellular degradation in hepatic cells (21, 22). Remarkably, some
molecules of ubiquitin-conjugated apoB can be rescued from degradation
and secreted when hepatocytes are treated with lipids (23). The variety
of pathways of degradation and possibility of rescue implies that
several types of proteins might play roles in determining the fate of
molecules of apoB.
To gain a more complete view of the assembly, degradation, and
regulation of the secretion of apoB, we wished to identify proteins
that contact apoB throughout its biogenesis in the hepatocyte. We
employed a proteomic approach to isolate and identify all proteins that
could be co-immunoprecipitated with apoB after treatment with a
chemical cross-linker. We demonstrate that some of the novel proteins
bind to apoB and therefore are candidates for roles in its biogenesis.
Reagents--
Janet Sparks kindly provided us with a gift of
polyclonal antibody against rat apoB; goat polyclonal antibody against
human apoB was purchased from Chemicon. The monoclonal antibodies 1D1, Bsol1, and Bsol7 were kindly given by Yves Marcel. Protein G-agarose was purchased from Kirkegaard and Perry Laboratories. Silver staining kits were obtained from BioRad. The chemical cross-linkers
dithiobis(succinimidyl propionate) (DSP), disuccinimidyl suberate
(DSS), and dimethyl 3,3'-dithiobispropionimidate-2 HCl (DTBP) were
obtained from Pierce. Colloidal Blue staining kits were purchased from
Novex. The plasmid TyB2, ER2566 bacteria, and chitin beads were
purchased from New England Biolabs. A kit for generating capped
mRNA using SP6 polymerase was purchased from Ambion. Rabbit
reticulocyte lysate was from Promega, and [35S]methionine
Tran35S-label (specific activity >1000 Ci/mmol) was
purchased from ICN. Ultrafree MC 0.22 µm filter units were purchased
from Millipore.
Preparation of Microsomes--
Livers averaging 4 g
each from adult Sprague-Dawley rats of various ages were excised
shortly after euthanasia and transported in ice-cold homogenization
buffer (HB: 50 mM sodium phosphate, 50 mM
potassium acetate, 1 mM EDTA, 0.25 M sucrose, 1 mM phenylmethylsulfonyl fluoride, pH 7.5). The
livers were rinsed four times in HB, cut into very small pieces, and
passed several times through a parsley grinder. The liver was
homogenized in HB using a motorized Teflon-coated Dounce homogenizer at
high speed. Tissue debris was removed by centrifugation at 10,000 rpm
at 4 °C for 15 min. The supernatant was transferred to a new tube
and centrifuged again at 12,000 rpm at 4 °C for 15 min. The
supernatant then was layered onto 4 ml of HB adjusted to 1.3 M sucrose and centrifuged at 28,000 rpm at 4 °C for
3 h using an AH-629 rotor. After removing the supernatant, the
jelly-like microsomal pellet was collected and gently dispersed in a
small volume of HB using a hand-held Teflon-coated Dounce homogenizer.
Cross-linking--
We used DSP and DTBP for cross-linking
proteins in our samples. Both cross-linking reagents are cleavable,
homobifunctional, have similarly sized spacer arms, and permeate
membranes. However, unlike DSP, DTBP is readily soluble in aqueous
solutions. DSP was dissolved in dimethyl sulfoxide
(Me2SO) and added to the sample at a final
concentration of 25 mM. DTBP was added directly to the
sample at a concentration of 10 mM. Chemical cross-linking was carried out in homogenization buffer. The reaction was incubated at
room temperature for 30 min then stopped by adding Tris-HCl to 50 mM and incubating another 15 min. The cross-linked
microsomes were collected by centrifugation at 90,000 rpm for 15 min at
4 °C in a Beckman TL-100 tabletop ultracentrifuge.
For some experiments, antibodies were conjugated to either cyanogen
bromide-activated beads or cross-linked to protein G-agarose. Cyanogen
bromide-activated beads were washed with cold 1 mM HCl for
30 min, followed by brief washes with water and then buffer A (0.1 M NaHCO3/0.5 M NaCl (pH 8.5)).
Antibody was incubated with the beads for 2 h at room temperature.
Unreacted groups were blocked with 1 M ethanolamine (pH
8.0) for 2 h at room temperature. The beads were washed
extensively with buffer A followed by five washes with 0.1 M acetate (pH 4.0)/0.5 M NaCl. Finally, the beads were washed with TXSWB (1% Triton X-100, 100 mM Tris-HCl (pH
8.0), 100 mM NaCl, 10 mM EDTA, 1 mM
phenylmethylsulfonyl fluoride) and used for immunoprecipitation.
Protein G-agarose was incubated with antibodies in 50 mM
sodium borate (pH 8.2) overnight at 4 °C on a rotator. The beads
were washed first with sodium borate buffer and then with 0.2 M triethanolamine buffer (pH 8.2). The non-cleavable
cross-linker DSS (10 mM) was added, and the reaction was
incubated at room temperature for 1 h. After washing with triethanolamine buffer, the beads were incubated in 0.1 M
ethanolamine (pH 8.2) for 10 min at room temperature. The beads were
washed in 0.1 M glycine-HCl (pH 2.8) and then in sodium
borate buffer. Finally, the washed beads were equilibrated in TXSWB and
used for immunoprecipitation.
Immunoprecipitation--
Aliquots of microsomes were
completely dissolved in TXSWB; no unsolubilized material remained.
Antibody against apoB was added in the form of serum or conjugated to
beads (as described above). After incubating the sample with antibody
for 1 h at 4 °C, protein G-agarose beads were added to samples
containing free antibody in solution, and the tubes were rotated
overnight at 4 °C. Subsequently, the beads were washed three times
with TXSWB and twice with Tris-NaCl (100 mM Tris-HCl (pH
8.0), 100 mM NaCl). The immunoprecipitated proteins were
released by boiling for 10 min in SDS loading buffer containing 0.5 M dithiothreitol (DTT) and separated by SDS-PAGE.
Cloning of Ferritin Heavy and Light Chain Coding Regions and
Plasmid Constructions--
Total RNA was prepared from a confluent T75
flask of HepG2 cells using 2 ml of solution I (4 M
guanidine thiocyanate, 20 mM sodium acetate, 0.5%
Sarkosyl, and 0.1 mM DTT). The lysate was mixed by
inversion with 0.2 ml of 2 M sodium acetate (pH 4), then 2 ml of water-saturated phenol, and finally 0.4 ml of chloroform. After
mixing, the solution was kept on ice for 15 min and then centrifuged at
10,000 × g for 20 min at 4 °C. The aqueous phase was transferred to a new tube, and the RNA was precipitated with 2 ml
of isopropanol by storing the solution at
Poly(A)-containing mRNA was purified from this total RNA. Oligo dT
cellulose was washed in 0.1 M sodium hydroxide, rinsed several times in diethyl pyrocarbonate-treated water until the pH value
of the wash was neutral, and then resuspended in 0.5 M
lithium chloride, 10 mM Tris acetate (pH 7.5), 1 mM EDTA, and 0.1% SDS. The RNA solution was heated to
70 °C for 10 min, adjusted to 0.5 M lithium chloride,
and incubated with the oligo dT cellulose on a rotator at room
temperature for 1 h. The oligo dT cellulose was recovered by
centrifugation in a microcentrifuge at maximum speed for 30 s. The
oligo dT cellulose was washed twice with 0.15 M lithium
chloride, 10 mM Tris acetate (pH 7.5), 1 mM
EDTA, and 0.1% SDS. After the second wash, the resuspended cellulose
was transferred to an Ultrafree MC 0.22 µm filter unit. The cellulose was washed three more times in the filter unit followed by
centrifugation for 30 s in a microcentrifuge at maximum speed.
After the final wash, the filter cup was transferred to a new tube, and
the poly(A)-containing RNA was eluted using 2 mM EDTA/0.1% SDS.
The poly(A)-containing RNA was used to synthesize cDNAs for the
ferritin chains. First strand cDNA was synthesized using
Superscript II reverse transcriptase (Invitrogen) according to
the manufacturer's instructions. The cDNAs were used as templates
to generate PCR products encoding ferritin heavy or light chains using
primers corresponding to the amino- and carboxyl-terminal ends
(R1Nde-FerritinH, GGAATTCCATATGACGACCGCGTCCACCTCG;
KpnInt-FerritinH, GGGGTACCCTTGGCAAAGCAGCTTTCATTATCACTGTCTCCC; R1Nde-FerritinL, GGAATTCCATATGAGCTCCCAGATTCGTCAG; KpnInt-FerritinL, GGGGTACCCTTGGCAAAGCAGTCGTGCTTGAGAGTGA). The PCR products were inserted into the plasmid TyB2 at NdeI and KpnI
recreating the amino acid residues in the intein so that no additional
amino acid residues were encoded between ferritin and the intein.
Individual plasmids were verified by sequencing.
Fusion Protein Preparation--
The plasmids encoding the
ferritin fusion proteins and TyB2 itself were transfected into the
ER2566 strain of Escherichia coli, and overnight cultures
were prepared from single colonies. The next day, the culture was
diluted 1:10, and after 1 h 0.2 mM isopropyl
thiogalactopyranoside was added. After 5 h, the cells were
pelleted by centrifugation at 5000 × g for 10 min at
4 °C. The pellet was resuspended in phosphate-buffered saline and
disrupted over the horn of a sonicator (Heat Systems-Ultrasonics, Inc.) for a total of 5 min using pulses of 1 min interrupted by cooling on
ice. After sonication, the solution was brought to 1% Triton X-100 and
mixed gently by inversion, and aliquots were spun in a microcentrifuge
at maximum speed for 5 min at 4 °C. The supernatants were pooled in
a new tube and incubated with chitin beads on a rotator at room
temperature for 7 min. The beads were collected by centrifugation at
500 × g for 5 min at 4 °C and washed three times
with phosphate-buffered saline. Aliquots of the fusion proteins bound
to chitin beads were displayed by SDS-PAGE and quantitated by Coomassie staining.
Binding Assay--
The plasmid pSPB29 encoding apoB29 (the
amino-terminal 29% of apoB) downstream of the SP6 promoter was created
by inserting a linker encoding a termination codon at the first
AccI site in the plasmid pSPB48 (pSP64 with the
5'-untranslated region of Xenopus globin and apoB48 coding
region). This plasmid was used as a template for transcription by SP6
polymerase using a kit. Subsequently, the mRNA was translated into
[35S]methionine-labeled protein using rabbit reticulocyte
lysate. Two microliters of lysate containing the translation product
was diluted in 250 µl of TXSWB and incubated with 6 µg of the
fusion proteins bound to beads on a rotator at room temperature for
4 h. The beads were collected by centrifugation at maximum speed in a microcentrifuge and washed three times with 1 ml of TXSWB and two
times with Tris-NaCl buffer. The washed beads were then incubated in
SDS loading buffer with 0.5 M DTT for 30 min and then
boiled for 10 min. The proteins were resolved by SDS-PAGE and
visualized by Coomassie staining followed by autoradiography. Coomassie
staining was performed to verify that equivalent amounts of fusion
proteins were used in the binding assays.
Strategy to Identify Proteins That Bind to ApoB--
Our approach
to isolate proteins bound to apoB involved two forms of purification
(Fig. 1A). First, we separated
intact microsomes containing nascent apoB and associated proteins from
cytosolic, nuclear, plasma membrane, and other organellar compartments.
Once microsomes were prepared, the proteins were cross-linked using cleavable, homobifunctional, chemical cross-linkers reactive toward amino groups. In the second purification step, apoB and cross-linked proteins were co-immunoprecipitated using polyclonal antibody against
apoB. During preparation of the isolated proteins for SDS-PAGE, the
samples were treated with 0.5 M DTT, which cleaves the
disulfide bond in the chemical cross-linking agents. The
co-immunoprecipitated proteins were then separated by SDS-PAGE and
visualized by staining (Fig. 1A).
We anticipated needing a large quantity of antibodies for
immunoprecipitating rat apoB. However, antibodies against rat apoB are
not commercially available. Because apoB is such a large protein, it is
likely that several epitopes are conserved in both rat and human apoB.
Therefore, we screened commercially available antibodies raised against
human apoB for reactivity against rat apoB. We specifically sought an
antibody that would immunoprecipitate rat apoB as efficiently as an
aliquot of antiserum raised against rat apoB that was kindly provided
by Janet Sparks. Aliquots of rat liver homogenate were subjected to
immunoprecipitation using some polyclonal and some monoclonal
antibodies against human apoB. For comparison, the polyclonal antibody
against rat apoB was used for immunoprecipitation of one aliquot. The
immunoprecipitated apoB was visualized by Western blotting using the
antibody against rat apoB (Fig. 1B). The monoclonal
antibodies appear specific to epitopes in human apoB that are not
present in rat apoB (Fig. 1B, lanes 2-4). The
three commercial polyclonal antibodies against human apoB had varying
efficacy in immunoprecipitating rat apoB (Fig. 1B,
lanes 5-7). We found that polyclonal antibody against human
apoB obtained from Chemicon International immunoprecipitated rat apoB48
and apoB100 as well as antibody raised against rat apoB (Fig.
1B, compare lanes 1 and 7). We used
antibody from the same lot from Chemicon for all subsequent experiments.
Co-immunoprecipitation of Proteins Cross-linked to ApoB--
In
an effort to detect proteins that bind to apoB, we prepared microsomes,
treated some aliquots with chemical cross-linkers, and subjected the
solubilized proteins to immunoprecipitation with antibody against apoB.
Uncross-linked samples showed a sharp band of apoB near the top of the
gel and a few other bands of faster migration (Fig.
2, lane 1). Two broad bands
corresponding to the eluted heavy and light chains dominate each lane
(Fig. 2). When the intact microsomes were treated with the cross-linker DSP, some new bands are visible (Fig. 2, lane 2;
e.g. see the 18-29-kDa range). When cross-linking was
carried out using DTBP, many new bands emerge (Fig. 2, lane
3). This pattern of bands was consistent despite variations in the
concentration of microsomal protein during cross-linking (data not
shown). Furthermore, we always detected more bands using DTBP compared
with DSP (data not shown). We selected DTBP for further studies because
a larger amount of proteins are cross-linked to apoB with this reagent (Fig. 2). Because the length of the spacer arm between the two reactive
imidoester groups of DTBP is 11.9 Å, these bands correspond to
proteins that contact or are within close proximity to apoB.
The prominent bands corresponding to heavy and light chains posed two
problems. First, the increased amount of antibody necessary for a
larger scale preparation for protein sequencing would overload and
distort the gel lane. Second, the broad bands obscure underlying and
neighboring bands rendering them undetectable. Attempts to elute apoB
from the polyclonal antibody while leaving antibody bound to the solid
matrix were unsuccessful.
Therefore, we cross-linked the antibodies to protein G-agarose and
used the conjugated antibodies for immunoprecipitation. Antibodies were
conjugated via coupling to cyanogen bromide-activated beads or by
cross-linking antibodies on protein G-agarose using the non-cleavable
agent DSS. Once conjugation was complete, the beads were washed several
times to remove unbound antibodies. We verified that the conjugated
heavy and light chain did not elute visibly from the beads despite
boiling in SDS and DTT (data not shown). Using conjugated
antibodies, we compared the proteins immunoprecipitated from aliquots
of uncross-linked microsomes (Fig. 3,
lane 1) with microsomes treated with DTBP (Fig. 3,
lane 2). The conjugated antibody co-immunoprecipitated
several proteins that are not readily evident in the uncross-linked
sample. Furthermore, the conjugated antibody co-immunoprecipitated a
very similar pattern of proteins from cross-linked microsomes as did
unconjugated antibodies (free in solution) that were collected
subsequently on protein G-agarose (Fig. 3, compare lanes 2 and 3). The pattern and intensity of the bands is very
similar regardless of whether the antibodies were conjugated. The lack
of heavy and light chains from the conjugated antibody reveals other
bands (Fig. 3, lane 2) and permits increasing the scale of
the purification without overloading the gel with protein. Thus,
conjugated antibody offers significant advantages without significantly
altering the recovery of co-immunoprecipitated proteins.
Purification and Sequencing of Proteins--
Using this approach
to isolate proteins that co-immunoprecipitate with apoB, we purified
sufficient masses of each band for protein sequencing by mass
spectrometry. In the previous analytical scale experiments, silver
staining was used to detect bands that in some cases were at the
threshold of detection in the range of 1 ng. To ensure adequate
recovery of peptides from the gel, we anticipated needing roughly
50-100 ng of each band. Microsomes were prepared from the livers of
four adult rats, treated with DTBP, solubilized, and subjected to
immunoprecipitation with conjugated antibody against apoB. After
cleaving the cross-linker, the released proteins were separated in one
lane by SDS-PAGE and visualized using a colloidal Coomassie stain. This
staining kit has a reported sensitivity of 10 ng. The gel used for
sequencing is shown in Fig. 4. In view of
the cost of protein sequencing, we excised and pooled bands of similar
migration into nine pools.
The excised bands were given to the Harvard Microchemistry Facility for
sequencing. After the proteins were digested with trypsin in the
gel, the released peptides were sequenced by microcapillary reverse-phase high pressure liquid chromatography nano-electrospray tandem mass spectrometry on a Finnigan LCQ quadrupole ion trap mass
spectrometer. The peptide data was correlated with known sequences
using the algorithm Sequest (24) and programs developed at the Harvard
Microchemistry Facility (25). Finally, the peptide sequences were
reviewed manually for fidelity and consensus with known proteins.
A total of 377 peptides were matched to 120 known data base entries and
99 unique proteins. The proteins identified in each pool of bands is
shown in Fig. 5. The peptides ranged in
length from seven to 31 amino acid residues. On average, the median
lengths were nearly 14 amino acid residues. The chance of an exact
match of two peptide sequences over 14 amino acids is about 1:1.6 × 1018. This calculation lends considerable credence to
the identity of the matched protein, and the presence of longer or
multiple peptides corresponding to the same protein strengthens the
identification further. Two contaminants did show up in our results.
Despite an effort to handle the gel with washed gloves as little as
possible, keratin was detected by this highly sensitive procedure in
four of the nine pools of bands and accounted for 18 of the matches overall. This contamination also could have occurred during handling of
the glass plates prior to pouring the gel. The other contaminant stems
from the immunoglobulin chains that eluted from the beads probably in
small amounts because they account for 22 of the 377 peptides. Thus, 40 of the 377 peptides could be the result of contamination. The rest of
the matches appear to derive from the samples. Nearly all of the
peptides correspond to proteins of molecular mass that match their
group indicating that significant degradation did not occur. (Note that
the range of apparent molecular masses of the matched proteins,
estimated from where the bands were excised, is approximate especially
for proteins of slower migration.) The principal exceptions are
peptides from keratin at scattered places on the gel, uricase (also
called urate oxidase), Ferritin Chains Can Bind ApoB Directly--
Proteins identified by
cross-linking and co-immunoprecipitation could contact or simply
be located within about a 12-Å range of apoB. We investigated whether
some of the proteins discovered can bind apoB directly. We chose to
investigate the binding of apoB by ferritin heavy and light chains due
to their interaction detected in other types of
experiments.2 We found that
small amounts of apoB can be co-immunoprecipitated from HepG2 cells in
the absence of a cross-linker using antibodies against
ferritin; at these levels of co-immunoprecipitation, however, it is
difficult to rule out cross-reactivity of the antibodies with epitopes
on apoB (data not shown). Furthermore, if binding is brief in cells,
the association might not be detected easily without using a
cross-linker.
To circumvent these issues, we investigated whether these candidates
can bind to apoB directly in vitro. We constructed plasmids encoding fusion proteins with ferritin heavy and light chains. First,
we cloned the coding sequences for ferritin heavy and light chains by
reverse transcription-PCR using mRNA from HepG2 cells. The
PCR products were engineered into the plasmid TyB2 and verified by
sequencing. The resulting plasmids encoded ferritin heavy or light
chain fused to an intein and chitin-binding domain (Fig. 6A). These ferritin fusion
proteins and the product of unmodified TyB2 (the multiple cloning site,
intein, and chitin-binding domain) were expressed in E. coli
and purified by binding to chitin beads.
The binding assay was carried out using equal masses of the three
proteins (bound to beads) and [35S]methionine-labeled
apoB29 (the amino-terminal 29% of apoB) that was synthesized using
rabbit reticulocyte lysate. ApoB29 is a large protein (molecular mass,
~150 kDa) that still can be translated efficiently in
vitro. We found that both of the ferritin fusion proteins bound
apoB29, with the fusion protein encoding ferritin heavy chain having
the greatest affinity (Fig. 6B, lanes 1 and 2). In contrast, the intein and chitin-binding domain by
themselves did not bind apoB29 well (Fig. 6B, lane
3). Furthermore, the lack of binding of globin or other unlabeled
proteins in the lysate to the ferritin fusion proteins, as ascertained
by Coomassie staining of the gel (data not shown), indicates that the
binding of apoB by ferritin is specific. Thus, ferritin heavy and light
chains not only can be cross-linked to apoB in microsomes prepared from rat livers but also can bind apoB directly. These proteins are candidates for roles in the biogenesis of apoB.
We developed a biochemical approach to purify proteins associated
with apoB. This strategy has its advantages and its limitations. Proteins in microsomes derived from rat livers were treated with a
chemical cross-linker. This step enables detection of proteins that
might bind apoB too weakly to remain associated throughout the
immunoprecipitation procedure. The downside of using a cross-linker is
that proteins that are in close proximity (i.e. within about 11.9 Å, the length of the spacer arm) but not actually in contact could become cross-linked to apoB. Thus, the use of a chemical cross-linker results in decreased specificity as the price for increased sensitivity. Relatively few proteins, however, are
co-immunoprecipitated with apoB when the microsomes were not treated
with a chemical cross-linker (see Fig. 3, lane 1, and the
few bands seen in Fig. 2, lane 1). Therefore, we chose to
use a cross-linker. In the second stage of purification, the microsomes
were solubilized, and the proteins were co-immunoprecipitated with
antibody against apoB. Polyclonal antibodies often cross-react with
other proteins. However, the relative lack of proteins other than apoB
in the uncross-linked sample attests to the specificity of the
immunoprecipitation step (Fig. 3, lane 1). The combination
of microcapillary high pressure liquid chromatography and tandem mass
spectrometry is a powerful and sensitive tool for protein sequencing.
This sensitivity has its limitations, too. Even small amounts of
contamination with human keratin from handling the gel, glass plates,
or container for staining can be detected. Some proteins might have
been masked by the large number of ribosomal proteins cross-linked to
nascent apoB or diluted below detection by pooling bands. A few
anticipated proteins, including MTP, calnexin, calreticulin, and GRP94,
did not appear in the list of matches. Apparently, these proteins failed to be cross-linked to apoB or were recovered in inadequate amounts from co-immunoprecipitation, or too few peptides of suitable lengths were released from the gel or reverse phase high pressure liquid chromatography for detection. Furthermore, a peptide from rat
MTP may have been unmatched by the algorithms used. The sequence for
rat MTP is not currently in the data base. MTP from humans, hamsters,
and cows are highly homologous and about 85% identical in sequence,
and rat MTP might match MTP of other species to a similar degree. The
stringent matching process used, however, requires identity
over the entire tryptic peptide and not just homology. All of these
limitations of our biochemical approach were accepted in view of the
lack of a tractable genetic or in vitro system to study the
biogenesis of such a large and complex protein. Despite these
shortcomings, this strategy did identify proteins that bind to
apoB.
Many ribosomal proteins were cross-linked to presumably incompletely
elongated chains of apoB. When lipid synthesis is limiting in HepG2
cells, apoB proteins that appear to be full-length can be incompletely
synthesized and remain in functional association with the ribosome and
translocation machinery in the ER membrane (26). Thus, it is not
surprising that such a large number of ribosomal proteins were
cross-linked to apoB in rat liver microsomes.
This biochemical approach yielded 50 proteins other than ribosomal
proteins and contaminants. Some known chaperone proteins were
identified, including members of the PDI family and BiP. Despite a lack
of evidence for degradation, peptides matching PDI and BiP were found
not only in their appropriate size range but also in pool 3. These
single peptides may have been cleaved from smaller proteins than these
known chaperones that serve similar functions. One matched protein,
fatty acyl co-A ligase (27), is an enzyme involved in triglyceride
biosynthesis, which can affect the secretion of apoB (28-30). Fatty
acyl co-A ligase and apolipoprotein B can be found in the ER, and both
are enriched in the mitochondria-associated membrane fraction (31). Our
data raise the possibility that apoB is in close contact with this enzyme that synthesizes lipids to be transported. An enzyme that converts cholesterol esters to free cholesterol, cholesterol ester hydrolase (32), was identified. This result may fit in with the growing
body of evidence that the pathways for hepatic cholesterol metabolism
and lipoprotein secretion intersect (2, 33). Another steroid metabolic
enzyme, 11- Our strategy did identify some novel proteins that can bind to apoB. We
show that ferritin heavy and light chains can bind apoB. This result
raises several questions. Do ferritin heavy and light chains play a
role in the biogenesis of apoB? Where do these cytosolic proteins bind
on apoB? Do the iron storage and lipoprotein secretion pathways
intersect? What other proteins that were cross-linked to apoB likewise
bind apoB? We are currently investigating these questions.
We thank Marcel Tanudji for reading the
manuscript and helpful discussions. We thank Janet Sparks and Yves
Marcel for the gifts of antibodies.
*
This work was supported by Grant HL62545 from NHLBI,
National Institutes of Health.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Current address: CytoGenix, Inc., Houston, TX 77099.
¶
Current address: University of Rennes, 35042 Rennes
Cédex, France.
Published, JBC Papers in Press, April 4, 2002, DOI 10.1074/jbc.M112448200
2
S. Hevi and S. L. Chuck, unpublished observations.
The abbreviations used are:
apoB, apolipoprotein
B;
PDI, protein disulfide isomerase;
ER, endoplasmic reticulum;
MTP, microsomal triglyceride transport protein;
DSP, dithiobis(succinimidyl propionate);
DSS, disuccinimidyl suberate;
DTBP, dimethyl 3,3'-dithiobispropionimidate-2 HCl;
DTT, dithiothreitol.
A Proteomic Approach Identifies Proteins in Hepatocytes That Bind
Nascent Apolipoprotein B*
,
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
20 °C for 30 min before
centrifuging at 10,000 × g for 15 min at 4 °C. The
RNA pellet was dissolved in 0.3 ml of solution I and precipitated again
with 0.3 ml of isopropanol. The RNA pellet was resuspended in 75%
ethanol at room temperature and spun at 10,000 × g for 15 min at 4 °C. The pellet was air-dried and resuspended in 100 µl
of diethyl pyrocarbonate-treated water.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (27K):
[in a new window]
Fig. 1.
A, strategy for the purification of
proteins associated with apoB. See "Experimental Procedures" for
details. B, one polyclonal antibody against human apoB can
efficiently immunoprecipitate rat apoB. Rat livers were homogenized and
solubilized in TXSWB. Equal dilutions of antibody were added to
aliquots of the homogenate, and immunoprecipitation of rat apoB was
carried out. The washed immunoprecipitates were separated on an 8%
polyacrylamide gel and transferred to Hybond C Super membrane
overnight. The blot was probed with antibody against rat apoB and
visualized via chemiluminescence. Bands for apoB100 and apoB48, both of
which are synthesized in rat liver, are seen in some lanes. The
antibodies used for immunoprecipitation of the aliquots is indicated in
the labels above the blot: rat, polyclonal antibody against
rat apoB; 1D1, Bsol1, and
Bsol7, monoclonal antibodies against human apoB;
X and Y, two commercial polyclonal antibodies
against human apoB; C, Chemicon polyclonal antibody against
human apoB.

View larger version (43K):
[in a new window]
Fig. 2.
Many proteins can be cross-linked to
apoB. Microsomes were prepared from rat livers, and some aliquots
were treated with either of the chemical cross-linkers DSP or DTBP.
After quenching the cross-linking reaction, the microsomes were
collected and solubilized in TXSWB. Antibody against apoB and then
protein G-agarose beads were added to the samples, and the
immunoprecipitated proteins from the washed beads were separated on a
15% gel and visualized by silver staining. In lane 1 (Un), the microsomes were not treated with a cross-linker.
In lanes 2 (DSP) and 3 (DTBP),
microsomes were treated with the respective cross-linkers prior to
immunoprecipitation. The positions of molecular mass markers are
indicated on the right.

View larger version (57K):
[in a new window]
Fig. 3.
Antibodies conjugated to beads
co-immunoprecipitate cross-linked proteins without visible heavy and
light chains. Aliquots of rat liver microsomes were left untreated
(lane 1) or cross-linked with DTBP (lanes 2 and
3). The solubilized microsomes were subjected to
immunoprecipitation with either antibody conjugated to cyanogen
bromide-activated beads (lanes 1 and 2) or free
antibody against apoB in solution followed by the addition of protein
G-agarose (lane 3). The washed immunoprecipitates were
displayed on a 15% gel followed by silver staining. The positions of
molecular mass markers are indicated on the left.

View larger version (25K):
[in a new window]
Fig. 4.
Preparative gel used for isolating proteins
for sequencing. Microsomes were prepared from livers of four adult
rats, cross-linked with DTBP, and solubilized in TXSWB. A total of 14 mg of microsomal protein was subjected to immunoprecipitation using an
antibody cross-linked to protein G-agarose with the non-cleavable
reagent DSS. The immunoprecipitated proteins were released by
incubating the washed beads with SDS loading buffer and 0.5 M DTT. The proteins were electrophoresed on a 15%
acrylamide gel and stained using colloidal Coomassie. The bands were
excised using sterile scalpels, grouped into 9 pools, and sent for
microsequencing. The numbers and lines on the right indicate
the pools.
and
globin, one peptide matching a
cytochrome P450 enzyme, and two peptides that match PDI and BiP found
in pool 3 (in the 20-kDa range). There were 40 unique ribosomal
proteins identified. Presumably, these proteins were cross-linked to
chains of apoB that had not finished elongation; the isolation of
translation elongation factor
also supports this idea. Most of the
remaining proteins are hepatic enzymes and not structural proteins,
although two forms of actin did occur. Cytochrome P450 enzymes
accounted for 12 matches. Of the 38 remaining proteins, some are known
to contact apoB during its biogenesis such as PDI and BiP. We next investigated whether some of these newly identified proteins can bind
apoB.


View larger version (74K):
[in a new window]
Fig. 5.
Table of proteins cross-linked to apoB
identified by sequencing. The pooled bands from Fig. 4 were
sequenced by mass spectrometry (see "Purification and Sequencing of
Proteins" for details). The size range of the pooled bands is
only an estimate. Proteins that were identified by exact peptide
matches are listed with their accession number in the National Center
for Biotechnology Information protein data base. If peptides matched
proteins from different species, the first match encountered in the
data base is shown. The molecular mass for each full-length protein in
the data base was calculated from its amino acid sequence; some of the
matched data base entries are for fragments (denoted frag).
The number of matching peptides and their median length are also shown.
Within each pool, the proteins are listed in descending order based on
the number of matching peptides. In pool 3, band 1a (10 kDa) was
included that is not readily visible in the scan of the preparative
gel.

View larger version (16K):
[in a new window]
Fig. 6.
Two of the identified proteins, ferritin
heavy and ferritin light chains, bind apoB. A, diagram
of fusion proteins. Fusion proteins were expressed that consist of
ferritin heavy or light chain followed by an intein and a
chitin-binding domain. The control fusion protein was expressed from
unmodified TyB2 and encoded the region of multiple cloning sites
(MCS), intein, and chitin-binding domain. The protein
domains are not represented to scale. B, the three fusion
proteins were expressed in E. coli and purified using chitin
beads. The bound proteins were then incubated with
[35S]methionine-labeled apoB29 that was synthesized using
rabbit reticulocyte lysate for 4 h on a rotator at room
temperature. After washing the beads, the proteins were eluted in SDS
loading buffer, separated on a 15% gel, and visualized by
fluorography. The positions of molecular mass markers are indicated on
the left.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
hydroxysteroid dehydrogenase (34), was also found. Five
matches are with uricase (urate oxidase), which accounted for 39 peptides overall. However, this enzyme cannot play a role in the
biogenesis of apoB in man because there is not a human homologue (35).
Similarly, L-gulono-
-lactone oxidase, a key enzyme in
ascorbic acid biosynthesis, is missing in humans rendering us
susceptible to scurvy (36). Twelve different cytochrome P450 enzymes
were isolated. As a family, these microsomal, heme-containing enzymes
are involved in the conversion of metabolites for excretion and
synthesis of steroid hormones, but they have not yet been implicated in
the biogenesis of apoB. Many other proteins also were isolated
including some that bind GTP, participate in vesicle trafficking, play
a key role in the conversion of vitamin A to retinoic acid, and
detoxify substances (e.g. glutathione S-transferase, epoxide hydrolase, and cytochrome P450
enzymes). These proteins might be intracellular neighbors that never
interact; alternatively, they might bind apoB and play novel roles in
its biogenesis.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
Current address: Cellular Genomics, Inc., Branford, CT 06405.
To whom correspondence should be addressed: Molecular Medicine
Unit, Beth Israel Deaconess Medical Center, RW663, 330 Brookline Ave.,
Boston, MA 02215. Tel.: 617-667-1625; Fax: 617-667-8040; E-mail:
schuck@caregroup.harvard.edu.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Davidson, N. O.,
and Shelness, G. S.
(2000)
Annu. Rev. Nutr.
20,
169-193[CrossRef][Medline]
[Order article via Infotrieve]
2.
Kang, S.,
and Davis, R. A.
(2000)
Biochim. Biophys. Acta
1529,
223-230[Medline]
[Order article via Infotrieve]
3.
Chan, L.,
Chang, B. H.,
Liao, W.,
Oka, K.,
and Lau, P. P.
(2000)
Recent Prog. Horm. Res.
55,
93-125[Medline]
[Order article via Infotrieve]
4.
Olofsson, S. O.,
Asp, L.,
and Boren, J.
(1999)
Curr. Opin. Lipidol.
10,
341-346[CrossRef][Medline]
[Order article via Infotrieve]
5.
Ginsberg, H. N.
(1997)
Clin. Exp. Pharmacol. Physiol.
24,
A29-A32[Medline]
[Order article via Infotrieve]
6.
Pullinger, C. R.,
North, J. D.,
Teng, B. B.,
Rifici, V. A.,
Ronhild de Brito, A. E.,
and Scott, J.
(1989)
J. Lipid Res.
30,
1065-1077[Abstract]
7.
Yang, C. Y.,
Chen, S. H.,
Gianturco, S. H.,
Bradley, W. A.,
Sparrow, J. T.,
Tanimura, M., Li, W. H.,
Sparrow, D. A.,
DeLoof, H.,
Rosseneu, M.,
Lee, F. S., Gu, Z. W.,
Gotto, A. M.,
and Chan, L.
(1986)
Nature
323,
738-742[CrossRef][Medline]
[Order article via Infotrieve]
8.
Knott, T. J.,
Pease, R. J.,
Powell, L. M.,
Wallis, S. C.,
Rall, S. C. J.,
Innerarity, T. L.,
Blackhart, B.,
Taylor, W. H.,
Marcel, Y.,
Milne, R.,
Johnson, D.,
Fuller, M.,
Lusis, A. J.,
McCarthy, B. J.,
Mahley, R. W.,
Levy-Wilson, B.,
and Scott, J.
(1986)
Nature
323,
734-738[CrossRef][Medline]
[Order article via Infotrieve]
9.
Ou, W. J.,
Cameron, P. H.,
Thomas, D. Y.,
and Bergeron, J. J.
(1993)
Nature
364,
771-776[CrossRef][Medline]
[Order article via Infotrieve]
10.
Linnik, K. M.,
and Herscovitz, H.
(1998)
J. Biol. Chem.
273,
21368-21373 11.
Stillemark, P.,
Boren, J.,
Andersson, M.,
Larsson, T.,
Rustaeus, S.,
Karlsson, K. A.,
and Olofsson, S. O.
(2000)
J. Biol. Chem.
275,
10506-10513 12.
Boren, J.,
Graham, L.,
Wettesten, M.,
Scott, J.,
White, A.,
and Olofsson, S. O.
(1992)
J. Biol. Chem.
267,
9858-9867 13.
Gordon, D. A.,
and Jamil, H.
(2000)
Biochim. Biophys. Acta
1486,
72-83[Medline]
[Order article via Infotrieve]
14.
Gordon, D. A.,
Jamil, H.,
Sharp, D.,
Mullaney, D.,
Yao, Z.,
Gregg, R. E.,
and Wetterau, J.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
7628-7632 15.
Wetterau, J. R.,
Aggerbeck, L. P.,
Bouma, M. E.,
Eisenberg, C.,
Munck, A.,
Hermier, M.,
Schmitz, J.,
Gay, G.,
Rader, D. J.,
and Gregg, R. E.
(1992)
Science
258,
999-1001 16.
Rustaeus, S.,
Lindberg, K.,
Boren, J.,
and Olofsson, S. O.
(1995)
J. Biol. Chem.
270,
28879-28886 17.
Asp, L.,
Claesson, C.,
Boren, J.,
and Olofsson, S. O.
(2000)
J. Biol. Chem.
275,
26285-26292 18.
Yeung, S. J.,
Chen, S. H.,
and Chan, L.
(1996)
Biochemistry
35,
13843-13848[CrossRef][Medline]
[Order article via Infotrieve]
19.
Fisher, E. A.,
Zhou, M.,
Mitchell, D. M., Wu, X.,
Omura, S.,
Wang, H.,
Goldberg, A. L.,
and Ginsberg, H. N.
(1997)
J. Biol. Chem.
272,
20427-20434 20.
Chen, Y., Le,
Caherec, F.,
and Chuck, S. L.
(1998)
J. Biol. Chem.
273,
11887-11894 21.
Wu, X.,
Sakata, N.,
Lele, K. M.,
Zhou, M.,
Jiang, H.,
and Ginsberg, H. N.
(1997)
J. Biol. Chem.
272,
11575-11580 22.
Fisher, E. A.,
Pan, M.,
Chen, X., Wu, X.,
Wang, H.,
Jamil, H.,
Sparks, J. D.,
and Williams, K. J.
(2001)
J. Biol. Chem.
276,
27855-27863 23.
Mitchell, D. M.,
Zhou, M.,
Pariyarath, R.,
Wang, H.,
Aitchison, J. D.,
Ginsberg, H. N.,
and Fisher, E. A.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
14733-14738 24.
Eng, J. K.,
McCormick, A. L.,
and Yates, J. R. I.
(1994)
J. Am. Soc. Mass. Spectrom.
5,
976-989[CrossRef]
25.
Chittum, H. S.,
Lane, W. S.,
Carlson, B. A.,
Roller, P. P.,
Lung, F. D.,
Lee, B. J.,
and Hatfield, D. L.
(1998)
Biochemistry
37,
10866-10870[CrossRef][Medline]
[Order article via Infotrieve]
26.
Pariyarath, R.,
Wang, H.,
Aitchison, J. D.,
Ginsberg, H. N.,
Welch, W. J.,
Johnson, A. E.,
and Fisher, E. A.
(2001)
J. Biol. Chem.
276,
541-550 27.
Suzuki, H.,
Kawarabayasi, Y.,
Kondo, J.,
Abe, T.,
Nishikawa, K.,
Kimura, S.,
Hashimoto, T.,
and Yamamoto, T.
(1990)
J. Biol. Chem.
265,
8681-8685 28.
Boren, J.,
Rustaeus, S.,
Wettesten, M.,
Andersson, M.,
Wiklund, A.,
and Olofsson, S. O.
(1993)
Arterioscler. Thromb.
13,
1743-1754 29.
Wu, X.,
Sakata, N.,
Lui, E.,
and Ginsberg, H. N.
(1994)
J. Biol. Chem.
269,
12375-12382 30.
Benoist, F.,
and Grand-Perret, T.
(1996)
Arterioscler. Thromb. Vasc. Biol.
16,
1229-1235 31.
Rusinol, A. E.,
Cui, Z.,
Chen, M. H.,
and Vance, J. E.
(1994)
J. Biol. Chem.
269,
27494-27502 32.
Ghosh, S.,
Mallonee, D. H.,
Hylemon, P. B.,
and Grogan, W. M.
(1995)
Biochim. Biophys. Acta
1259,
305-312[Medline]
[Order article via Infotrieve]
33.
Fleming, J. F.,
Spitsen, G. M.,
Hui, T. Y.,
Olivier, L., Du, E. Z.,
Raabe, M.,
and Davis, R. A.
(1999)
J. Biol. Chem.
274,
9509-9514 34.
Agarwal, A. K.,
Monder, C.,
Eckstein, B.,
and White, P. C.
(1989)
J. Biol. Chem.
264,
18939-18943 35.
Wu, X.,
Wakamiya, M.,
Vaishnav, S.,
Geske, R.,
Montgomery, C., Jr.,
Jones, P.,
Bradley, A.,
and Caskey, C. T.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
742-746 36.
Koshizaka, T.,
Nishikimi, M.,
Ozawa, T.,
and Yagi, K.
(1988)
J. Biol. Chem.
263,
1619-1621
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. L. Hrizo, V. Gusarova, D. M. Habiel, J. L. Goeckeler, E. A. Fisher, and J. L. Brodsky The Hsp110 Molecular Chaperone Stabilizes Apolipoprotein B from Endoplasmic Reticulum-associated Degradation (ERAD) J. Biol. Chem., November 9, 2007; 282(45): 32665 - 32675. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Siddiqi, S. Siddiqi, J. Mahan, K. Peggs, F. S. Gorelick, and C. M. Mansbach II The Identification of a Novel Endoplasmic Reticulum to Golgi SNARE Complex Used by the Prechylomicron Transport Vesicle J. Biol. Chem., July 28, 2006; 281(30): 20974 - 20982. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. F. Morand, J. Macri, and K. Adeli Proteomic Profiling of Hepatic Endoplasmic Reticulum-associated Proteins in an Animal Model of Insulin Resistance and Metabolic Dyslipidemia J. Biol. Chem., May 6, 2005; 280(18): 17626 - 17633. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Qiu, R. Kohen-Avramoglu, S. Mhapsekar, J. Tsai, R. C. Austin, and K. Adeli Glucosamine-Induced Endoplasmic Reticulum Stress Promotes ApoB100 Degradation: Evidence for Grp78-Mediated Targeting to Proteasomal Degradation Arterioscler. Thromb. Vasc. Biol., March 1, 2005; 25(3): 571 - 577. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gilham, M. Alam, W. Gao, D. E. Vance, and R. Lehner Triacylglycerol Hydrolase Is Localized to the Endoplasmic Reticulum by an Unusual Retrieval Sequence where It Participates in VLDL Assembly without Utilizing VLDL Lipids as Substrates Mol. Biol. Cell, February 1, 2005; 16(2): 984 - 996. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hevi and S. L. Chuck Ferritins Can Regulate the Secretion of Apolipoprotein B J. Biol. Chem., August 22, 2003; 278(34): 31924 - 31929. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Hussain, J. Shi, and P. Dreizen Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly J. Lipid Res., January 1, 2003; 44(1): 22 - 32. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||